301 related articles for article (PubMed ID: 15842763)
1. Urine benzodiazepine screening using Roche Online KIMS immunoassay with beta-glucuronidase hydrolysis and confirmation by gas chromatography- mass spectrometry.
Klette KL; Wiegand RF; Horn CK; Stout PR; Magluilo J
J Anal Toxicol; 2005 Apr; 29(3):193-200. PubMed ID: 15842763
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the Microgenics CEDIA heroin metabolite (6-AM) and the Roche Abuscreen ONLINE opiate immunoassays for the detection of heroin use in forensic urine samples.
Holler JM; Bosy TZ; Klette KL; Wiegand R; Jemionek J; Jacobs A
J Anal Toxicol; 2004 Sep; 28(6):489-93. PubMed ID: 15516301
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of four immunoassay screening kits for the detection of benzodiazepines in urine.
DeRienz RT; Holler JM; Manos ME; Jemionek J; Past MR
J Anal Toxicol; 2008; 32(6):433-7. PubMed ID: 18652750
[TBL] [Abstract][Full Text] [Related]
4. The online screening technique for urinary benzodiazepines: comparison with EMIT, FPIA, and GC-MS.
Beck O; Lin Z; Brodin K; Borg S; Hjemdahl P
J Anal Toxicol; 1997; 21(7):554-7. PubMed ID: 9399125
[TBL] [Abstract][Full Text] [Related]
5. Identification of urinary benzodiazepines and their metabolites: comparison of automated HPLC and GC-MS after immunoassay screening of clinical specimens.
Valentine JL; Middleton R; Sparks C
J Anal Toxicol; 1996 Oct; 20(6):416-24. PubMed ID: 8889678
[TBL] [Abstract][Full Text] [Related]
6. KIMS, CEDIA, and HS-CEDIA immunoassays are inadequately sensitive for detection of benzodiazepines in urine from patients treated for chronic pain.
Darragh A; Snyder ML; Ptolemy AS; Melanson S
Pain Physician; 2014; 17(4):359-66. PubMed ID: 25054395
[TBL] [Abstract][Full Text] [Related]
7. CEDIA dau Benzodiazepine screening assay: a reformulation.
Meatherall RC; Fraser AD
J Anal Toxicol; 1998; 22(4):270-3. PubMed ID: 9681328
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the rates of hydrolysis of lorazepam-glucuronide, oxazepam-glucuronide and tamazepam-glucuronide catalyzed by E. coli beta-D-glucuronidase using the on-line benzodiazepine screening immunoassay on the Roche/Hitachi 917 analyzer.
Dou C; Bournique JS; Zinda MK; Gnezda M; McNally AJ; Salamone SJ
J Forensic Sci; 2001 Mar; 46(2):335-40. PubMed ID: 11305436
[TBL] [Abstract][Full Text] [Related]
9. A novel reductive transformation of oxazepam to nordiazepam observed during enzymatic hydrolysis.
Fu S; Lewis J; Wang H; Keegan J; Dawson M
J Anal Toxicol; 2010 Jun; 34(5):243-51. PubMed ID: 20529458
[TBL] [Abstract][Full Text] [Related]
10. Drug screening and confirmation by GC-MS: comparison of EMIT II and Online KIMS against 10 drugs between US and England laboratories.
Lu NT; Taylor BG
Forensic Sci Int; 2006 Mar; 157(2-3):106-16. PubMed ID: 15899564
[TBL] [Abstract][Full Text] [Related]
11. Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS.
Boettcher M; Haenseler E; Hoke C; Nichols J; Raab D; Domke I
Clin Lab; 2000; 46(1-2):49-52. PubMed ID: 10745981
[TBL] [Abstract][Full Text] [Related]
12. Measurement of benzodiazepines in urine by liquid chromatography-tandem mass spectrometry: confirmation of samples screened by immunoassay.
Glover SJ; Allen KR
Ann Clin Biochem; 2010 Mar; 47(Pt 2):111-7. PubMed ID: 19969595
[TBL] [Abstract][Full Text] [Related]
13. Benzodiazepine screening using EMIT II and TDx: urine hydrolysis pretreatment required.
Meatherall R
J Anal Toxicol; 1994; 18(7):385-90. PubMed ID: 7861751
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of five immunoassays for the analysis of alprazolam and triazolam metabolites in urine: effect of lowering the screening and GC-MS cut-off values.
Fraser AD; Meatherall R
J Anal Toxicol; 1996; 20(4):217-23. PubMed ID: 8835658
[TBL] [Abstract][Full Text] [Related]
15. Detection and confirmation of ractopamine and its metabolites in horse urine after Paylean administration.
Lehner AF; Hughes CG; Harkins JD; Nickerson C; Mollett B; Dirikolu L; Bosken J; Camargo F; Boyles J; Troppmann A; Karpiesiuk WW; Woods WE; Tobin T
J Anal Toxicol; 2004; 28(4):226-38. PubMed ID: 15189672
[TBL] [Abstract][Full Text] [Related]
16. New fluorescence polarization immunoassays for analysis of barbiturates and benzodiazepines in serum and urine: performance characteristics.
Schwenzer KS; Pearlman R; Tsilimidos M; Salamone SJ; Cannon RC; Wong SH; Gock SB; Jentzen JJ
J Anal Toxicol; 2000; 24(8):726-32. PubMed ID: 11110029
[TBL] [Abstract][Full Text] [Related]
17. Dried urine spots for detection of benzodiazepines.
Jain R; Quraishi R; Ambekar A; Verma A; Gupta P
Indian J Pharmacol; 2017; 49(6):465-469. PubMed ID: 29674802
[TBL] [Abstract][Full Text] [Related]
18. Comparison of immunoassay screening tests and LC-MS-MS for urine detection of benzodiazepines and their metabolites: results of a national proficiency test.
Bertol E; Vaiano F; Borsotti M; Quercioli M; Mari F
J Anal Toxicol; 2013; 37(9):659-64. PubMed ID: 23943436
[TBL] [Abstract][Full Text] [Related]
19. Rapid enzymatic hydrolysis using a novel recombinant β-glucuronidase in benzodiazepine urinalysis.
Morris AA; Chester SA; Strickland EC; McIntire GL
J Anal Toxicol; 2014 Oct; 38(8):610-4. PubMed ID: 25217555
[TBL] [Abstract][Full Text] [Related]
20. Benzodiazepine analysis by negative chemical ionization gas chromatography/mass spectrometry.
Fitzgerald RL; Rexin DA; Herold DA
J Anal Toxicol; 1993 Oct; 17(6):342-7. PubMed ID: 8271780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
